Simon Lucas is part of the Technology Foresight & Scouting team of Merck’s New Business Builder organization. In his role as an Innovation Field Explorer he is responsible for identifying, exploring, and developing unprecedented opportunities between and beyond the company’s existing offering. Simon joined Merck in 2018 from Evonik’s strategic innovation unit Creavis, where he was a project manager in the Sustainable Businesses unit, which supports the growth and sustainability strategy of Evonik by medium and long-term innovation projects for existing and new growth fields. Prior to this, he held various positions in medicinal chemistry and drug discovery at Grünenthal, Aachen, and Boehringer Ingelheim’s oncology research center in Vienna. Simon studied chemistry in Munich and Saarbrücken and received a PhD in medicinal chemistry from Saarland University in 2008. After postdoctoral stays at the University of Copenhagen and the Helmholtz Center for Infection Research, he began his career in the pharmaceutical industry in 2010.